Clean Energy raised its annual adjusted EBITDA outlook, with higher RNG volumes and tax-credit benefits supporting results. An $8.3 million catch-up complicates the quarterly run rate.
Read the story
StocksVisionSys disclosed a completed financing, but ordinary-share pricing, ADS conversion and dilution are essential to interpreting the headline.
StocksGogo's loan extension and decade-long spectrum renewal offer concrete catalysts, while Galileo adoption must translate into stronger overall financial results.
StocksErayak's manufacturing and hybrid-power update provides a concrete catalyst, while commercial launches, margins and cash conversion remain the next tests.
StocksSunCar's preliminary nine-month profit forecast and new repurchase authorization provide two concrete catalysts, with cash conversion and buyback execution still to prove.
StocksAnnovis Bio's share-and-warrant offering raises funding while adding ownership pressure, against the backdrop of a recent NYSE compliance notice.
StocksSANUWAVE faces a roughly 21% physician-office reimbursement reduction for 2027, while higher hospital payments offer a partial counterweight.
StocksElong Power's $3.26 million warrant agreement offers fresh funding while adding shares and potential future dilution after a volatile trading reversal.
StocksThredUp's holiday-quarter revenue forecast missed expectations, putting profitability and analyst downgrades in focus after a sharp selloff.
StocksTeads' weak quarter combines falling revenue, negative adjusted EBITDA and substantial debt; its large noncash impairment must be separated from cash burn.
StocksA revenue miss, weaker outlook and sales-team disruption explain why MNTN's growing earnings failed to reassure investors.
StocksFluent's growing commerce-media business explains why its next earnings release deserves attention, but losses and financing risk remain central.